Meet the MedCity Media Team

And take 2 minutes to help us make better for you.

Every year, we ask you to tell us a little about yourself (anonymously) to help us create better, more relevant content and features for you. We consider every response and very much appreciate you taking the time to assist us.

Please click the button above to open a simple, multiple choice survey that should only take 2 minutes to complete.

Thank you,

The MedCity Media Team

FDA flags new concerns on Hospira’s Rocky Mount plant

9:04 am by | 0 Comments

(Reuters) - Hospira Inc said U.S. health regulators issued a letter raising fresh concerns about one of the injectable-drugs maker's largest manufacturing plants in Rocky Mount, North Carolina, sending the company's shares down 4 percent.

Hospira's Rocky Mount facility has been under the FDA scanner since April 2010, when the regulator issued a warning letter stating manufacturing practices at the plant violated its defined standard practices.

The company said on Tuesday that the FDA inspected its Rocky Mount facility for three weeks and issued a letter outlining 20 concerns, three of which the agency had expressed earlier.

A number of these concerns were based on issues that are currently being resolved or have been identified by the company previously and would be addressed, Hospira said in a regulatory filing.


Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Hear the latest news first

Get our daily newsletter or follow us.